Company intelligence / Profile preview

Finnzymes

Espoo, Finland

Ownership: Private
Development stage: Other

Overview

Finnzymes was a Finnish biotechnology company specializing in the development and manufacturing of molecular biology reagents and equipment. The company was best known for its high-performance DNA polymerases, such as the Phusion High-Fidelity DNA Polymerase, which significantly improved PCR speed and accuracy. In addition to reagents, Finnzymes provided innovative PCR instruments and plastic consumables for life science research. The company was acquired by Thermo Fisher Scientific in 2010 and its products were integrated into the Thermo Scientific molecular biology portfolio.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Finnzymes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Finnzymes.

Explore the full profile